Finally, leveraging a phenotypic assay to systematically assess the activity of THAP1 mutants at the endogenous PSMB5 locus, we define the transcriptional activity of THAP1 mutants found in dystonia patients. The gene discussed is THAP1; the disease is Dystonia.